
Personen
Prof. Dr. Gerhard Gründer
Abteilungsleiter

Abteilung Molekulares Neuroimaging
Tel.: 0621 1703-1900
Fax: 0621 1703-801900
Therapiegebäude, EG, Raum 0.087
Sekretariat:
Hanna Böhm E-Mail
Tel.: 0621 1703-1901
Therapiegebäude, EG, Raum 0.089
Publikationen in peer-reviewed Zeitschriften seit 2006
TOP 5 Publikationen:
- , , , , , , , , , , , , . Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol Psychiatry. 2008 13(6):606-13, 557.
- , . The downside of downregulation. Brain. 2019 142(6):1500-1502.
- , , , , , , , , , , , , , , , , , , , , , , , , , . Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating. Proc Natl Acad Sci U S A. 2012 109(16):6271-6. Epub 2012 Mar 26.
- , , , , , . Dopamine and opioid systems adaptation in alcoholism revisited: Convergent evidence from positron emission tomography and postmortem studies. Neurosci Biobehav Rev. 2018 Sep 19. [Epub ahead of print].
- , , , , , , , , , , , . Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial. Schizophr Bull. 2019 45(2):350-359. Epub 2018 May 1.
Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de